表紙
市場調査レポート

家族性アミロイドポリニューロパチー(トランスサイレチンアミロイドーシス、Corino de Andrade Disease):世界の治験レビュー

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 302387
出版日 ページ情報 英文 99 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
家族性アミロイドポリニューロパチー(トランスサイレチンアミロイドーシス、Corino de Andrade Disease):世界の治験レビュー Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014
出版日: 2014年05月15日 ページ情報: 英文 99 Pages
概要

当レポートでは、家族性アミロイドポリニューロパチー(FAP)に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 家族性アミロイドポリニューロパチー(FAP)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:代謝異常症の治験件数に対する家族性アミロイドポリニューロパチー(FAP)の比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7(新興7カ国)における治験件数:代謝異常症の治験件数に対する家族性アミロイドポリニューロパチー(FAP)の比率

E7(新興7カ国)での治験件数:フェーズ(相)別

E7(新興7カ国)での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的企業の治験の概要
    • Pfizer Inc.
    • Alnylam Pharmaceuticals, Inc.
    • Isis Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
  • 代表的な研究機関・病院の治験の概要
    • Umea University
    • 信州大学
    • Boston University
    • Ospedale Policlinico San Matteo
    • Brigham and Women's Hospital
    • 熊本大学
    • IRCCS Policlinico San Matteo

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2136CTIDB

GlobalData's clinical trial report, "Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014" provides data on the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)
    • Jul 11, 2013: Alnylam Reports Positive Top-Line Results for ALN-TTRsc, a Subcutaneously Administered RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR-Mediated Amyloidosis
    • Mar 18, 2013: Alnylam Initiates Phase I Clinical Study For ALN-TTRsc For Treatment Of TTR-Mediated Amyloidosis
    • Feb 19, 2013: Isis Pharma Initiates Phase II/III Study Of ISIS-TTR Rx And Earns $7.5m Milestone Payment From GlaxoSmithKline
    • Aug 06, 2012: Alnylam Pharma Presents New Preclinical Data From 'Alnylam5x15' Programs Including ALN-TTRsc For Treatment Of Transthyretin-Mediated Amyloidosis
    • Jul 16, 2012: Alnylam Reports Positive Phase I Trial Results Of ALN-TTR02 For Treatment Of TTR-Mediated Amyloidosis
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Alnylam Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alnylam Pharmaceuticals, Inc.
      • Isis Pharmaceuticals, Inc.
      • Clinical Trial Overview of Isis Pharmaceuticals, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
    • Clinical Trial Overview of Top Institutes / Government
      • Umea University
      • Clinical Trial Overview of Umea University
      • Shinshu University
      • Clinical Trial Overview of Shinshu University
      • Boston University
      • Clinical Trial Overview of Boston University
      • Ospedale Policlinico San Matteo
      • Clinical Trial Overview of Ospedale Policlinico San Matteo
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • IRCCS Policlinico San Matteo
      • Clinical Trial Overview of IRCCS Policlinico San Matteo
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shinshu University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Policlinico San Matteo, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2014*

List of Figures

  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top